SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

COAR is a community-driven meme token on the Solana blockchain built around the theme of oil and energy. The project brings together a growing community of crypto enthusiasts who share an interest in energy-themed digital assets. COAR operates as a fully decentralized token with active trading on Solana decentralized exchanges. The token has a fixed maximum supply of 1 billion units with 6 decimal places, and its mint authority has been permanently revoked, making the supply immutable. The project features a dedicated website at coargov.com with real-time market data integration via DexScreener.

Chinese Oil Asset Reserve

COAR is gaining attention through a combination of oil-sector tokenization narratives, viral cultural memes, and speculative momentum. Market participants are actively debating the token's sustainability while scrutinizing its limited holder base and the aggressive community-driven hype surrounding its launch.

Invesco Exchange-Traded Fund Trust II - Invesco S&P 500 Momentum ETF

Invesco S&P 500 Momentum ETF

The Invesco S&P 500 Momentum ETF is trending as investors debate its role as a core portfolio holding, frequently highlighting its historical tendency to outperform traditional S&P 500 benchmarks over longer periods. Community discussions center on the pros and cons of its semi-annual rebalancing strategy, with some users favoring it as a "set it and forget it" momentum play, while others weigh it against more actively managed or frequently rotating alternatives.

Bill Holdings, Inc. engages in the provision of cloud-based software solutions. The firm simplifies, digitizes, and automates complex back-office financial operations for small and midsize businesses. Its software helps customers generate and process invoices, streamline approvals, send and receive payments, sync with their accounting systems and manage their cash. The company was founded by Rene Lacertea in April 2006 and is headquartered in San Jose, CA.

BILL Holdings Inc

Bill.com Holdings Inc

Bill.com Holdings is trending due to persistent speculation regarding a potential buyout, bolstered by active interest from activist investors like Starboard Value and Elliott Investment Management. The community remains heavily divided, with many traders holding for a premium acquisition while others express frustration over the stock's stagnant performance and valuation pressure.

Hyperliquid is a layer one (L1) blockchain best known for perpetual futures and spot trading. Beyond its flagship DEX trading platform, the ecosystem supports borrowing, lending, real world assets (RWAs), and a full-fledged Ethereum Virtual Machine (EVM), making it a leading force in decentralized finance (defi).   Just as electronic trading dramatically improved markets in the 2000s, Hyperliquid offers an opportunity for a massive technical upgrade of the existing financial system through a transparent, efficient, and resilient blockchain. HYPE is the native token of the Hyperliquid blockchain, with a maximum supply of 1 billion.

Hype

HYPE is attracting significant community attention as a key player in the decentralized perpetual exchange sector, with investors closely watching its high transaction volume and potential for market share expansion. The broader conversation is heavily influenced by its integration into institutional portfolios, upcoming token unlock schedules, and its ongoing role as a preferred venue for trading during periods of high geopolitical and market volatility.

Based Chad

CHAD is capturing market attention as a high-conviction play on the Base ecosystem, fueled by active community development, a multi-sig buyback flywheel, and upcoming video game partnerships. Investors are heavily discussing the asset's relative strength and perceived supply shock, often highlighting its status as an iconic, universally recognized meme supported by high-profile figures within the space.

Hyperliquid Strategies, Inc. is a holding and operating company, which engages in the business of crypto asset management. The firm operates as a digital asset treasury company which focuses on the Hyperliquid ecosystem. The company was founded on July 2, 2025 and is headquartered in New York, NY.

Hyperliquid Strategies Inc.

Hyperliquid Strategies Inc. is trending as investors capitalize on its deep ties to the Hyperliquid ecosystem and the strong performance of its HYPE token treasury. The community is actively debating the stock's role as a high-beta infrastructure proxy while navigating ongoing questions about NAV discounts and potential rotation from crypto-adjacent assets.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily S&P Biotech Bull 3X Shares

LABU is trending as retail investors capitalize on high-volatility price swings within the biotech sector, heavily influenced by leveraged trading strategies and ongoing community speculation regarding potential buyouts and FDA-related catalysts. Sentiment remains polarized between traders betting on sustained sector momentum driven by AI-led drug discovery and those anticipating a sharp mean reversion as leveraged decay impacts long-term holdings.

Waste Management, Inc. is a holding company, which engages in the provision of waste management environmental services. It operates through the following segments: Collection and Disposal-East Tier (East Tier), Collection and Disposal-West Tier (West Tier), Recycling Processing and Sales, Renewable Energy, and Healthcare Solutions. The East Tier segment includes the Eastern United States, the Great Lakes Region, and Canada. The West Tier segment refers to the upper Midwest region and British Columbia, Canada. The Recycling Processing and Sales segment focuses on the processing and sales of materials collected from residential, commercial, and industrial customers. The Renewable Energy segment develops, operates, and promotes projects for landfill gas use. The Healthcare Solutions segment relates to its primarily business to business company providing services that protect people and brands, promote health and well-being and safeguard the environment. The company was founded on September 30, 1987 and is headquartered in Houston, TX.

Waste Management, Inc.

Waste Management is attracting significant investor attention as a defensive "Steady Eddie" play amid broader market volatility, with community discussions centering on its essential service model, consistent dividend growth, and potential for margin expansion through AI integration and renewable natural gas. Investors are particularly focused on the stock's resilience during economic uncertainty, often comparing its stability to cyclical sectors while monitoring recent management efforts to optimize costs and operations.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X ETF

Direxion Daily S&P Biotech Bear 3X Shares

The community is actively debating the future of the biotechnology sector, with many investors closely monitoring XBI technical levels as a primary catalyst for trading the leveraged LABD ETF. Sentiment remains divided between those positioning for a potential sector reversal and those frustrated by continued bullish strength in biotech assets.

Analog Devices, Inc. is a semiconductor company, which engages in the combination of analog, digital, and software technologies into engineering solutions. Its products include analog and mixed signals, power management and reference, amplifiers radio frequency, and reference, sensors and actuators, and digital signal processing and system. The company was founded by Raymond P. Stata and Matthew Lorber in 1965 and is headquartered in Wilmington, MA.

Analog Devices Inc.

Analog Devices is trending as investors monitor its position in the semiconductor cycle following a series of analyst upgrades and active discussions about whether the stock represents a defensive play or a value-driven growth opportunity. The community is focused on the balance between recent price momentum, its role in AI infrastructure, and the potential for a broader rebound in the industrial and automotive chip segments.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

HeartBeam (NASDAQ: BEAT) Advances Commercial Launch, Reports First-Quarter 2026 Results

HeartBeam (NASDAQ: BEAT) reported first-quarter 2026 operational and financial results highlighted by the launch of its initial commercial partnerships in key U.S. markets, progress in its heart attack detection and ambulatory ECG patch initiatives, and an April public offering that raised $11.5 million in gross proceeds. The company reported a first-quarter net loss of $4.7 [&#8230;]

HeartBeam Q1 2026 Earnings Call: Complete Transcript

HeartBeam Reports First Quarter 2026 Results

HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, has reported its financial and operational results for the...

HeartBeam (NASDAQ: BEAT) Launches Pilot Study for On-Demand 12-Lead ECG Patch in Coronary Artery Disease Patients

HeartBeam (NASDAQ: BEAT)&#160;announced the initiation of a pilot study evaluating its investigational on-demand 12-lead ECG patch in approximately 50 patients with suspected coronary artery disease at two hospitals in Belgrade, Serbia. The study will compare synthesized 12-lead ECG readings generated by the company’s patch immediately following exercise stress testing against standard 12-lead ECGs, supporting&#160;HeartBeam’s&#160;regulatory strategy [&#8230;]

HeartBeam Initiates Pilot Study of First On-Demand 12-Lead ECG Patch to Detect Ischemia Outside the Clinic

HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, announced the initiation of a pilot study evaluating its...

<ul><li><i>Leading concierge practice Atelier Health, led by physicians affiliated with Cedars-Sinai, will now offer HeartBeam to its patients</i></li><li><i>Opens up flagship sites across New York, Dallas, South Florida and Southern California, supporting scalable expansion of HeartBeam technology in preventive cardiology</i></li><li><i>HeartBeam continues to execute on its go-to-market strategy in high-value, direct-pay care environments</i></li></ul><p>SANTA CLARA, Calif.--(BUSINESS WIRE)-- <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.heartbeam.com/"><strong>HeartBeam, Inc.</strong></a> (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced a commercial agreement with <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://atelier90210.com/">Atelier Health</a>, a premier concierge medical practice led by physicians affiliated with Cedars-Sinai Medical Center. The addition of Beverly Hills-based Atelier Health expands HeartBeam’s commercial footprint across four targeted launch markets – New York metro, Dallas, South Florida, and Southern California – completing an initial geographic footprint to advance the Company’s scalable go-to-market strategy in concierge and preventive cardiology.</p><p>The collaboration underscores HeartBeam’s positioning within the high-value direct pay healthcare segment where adoption of innovative technologies can occur more rapidly and patients are seeking proactive cardiac insights tailored to their individual risk profiles. Through its recently announced <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.heartbeam.com/news-events/press-releases/detail/110/heartbeam-announces-first-commercial-customer-as">partnership with ClearCardio™</a>, the Company has also established its initial presence in New York metro, Dallas, and South Florida. Atelier Health extends the network to Southern California, establishing HeartBeam’s initial commercial footprint across its targeted launch markets and providing a foundation for broader national expansion.</p><p>Atelier Health, which is expanding its Beverly Hills presence with enhanced imaging capabilities and rebranding as Generational Health, offers individualized preventive and diagnostic programs supported by advanced medical protocols, specialist-level access and world-class technology. Co-founder <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://atelier90210.com/leadership/">Ram Dandillaya, MD</a>, who previously served as Clinical Chief of Cardiology at Cedars-Sinai for 8 years, and his patients previously participated in HeartBeam’s Early Access Program, gaining firsthand experience with the Company’s patented cable-free 3D ECG technology. By capturing the heart’s electrical signals in three non-coplanar dimensions and synthesizing them into a 12-lead ECG, HeartBeam enables patients to obtain high-fidelity, clinical-grade ECG data for arrhythmia assessment from the comfort of home.</p><p>“Prevention is foundational to how we care for patients, which requires access to high-quality, meaningful data beyond the clinic,” said Dr. Dandillaya. “Our model is built on delivering the highest standard of specialist care with unmatched access and precision, and HeartBeam’s technology enables a more proactive, personalized approach to evaluating cardiac symptoms in real-world settings.”</p><p>“The addition of Atelier Health reflects the growing momentum behind our commercialization strategy,” said Robert Eno, Chief Executive Officer of HeartBeam. “With flagship sites now established across our initial launch markets, we are building a strong foundation for scalable growth. We believe partnering with leading concierge and preventive cardiology practices will continue to accelerate adoption of the HeartBeam System and expand access to clinical-grade cardiac insights beyond traditional care settings.”</p><p>This partnership advances HeartBeam's commercialization strategy across the concierge and preventive cardiology segment while validating its subscription-based business model. With multiple customers now established across key geographies, HeartBeam is building a repeatable model designed to support broader national expansion.</p><p><strong>About Atelier Health</strong></p><p>Atelier Health is a concierge medical practice based in Beverly Hills, California, delivering specialist-led healthcare with a focus on personalized prevention and treatment. The practice provides patients with 24x7x365 access to expert care, offering individualized programs supported by advanced medical protocols and world-class technology. Atelier Health’s physicians are affiliated with Cedars-Sinai Medical Center, which has been recognized by U.S. News &amp; World Report as one of America’s Best Hospitals. Atelier Health’s mission is to deliver compassionate, family-centered care while providing patients access to the highest standard of U.S.-based specialty medicine. Visit <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://atelier90210.com/">https://atelier90210.com/</a> for more information.</p><p><strong>About HeartBeam, Inc.</strong></p><p>HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company dedicated to transforming the detection and monitoring of critical cardiac conditions. The Company has developed the first-ever cable-free device capable of collecting ECG signals in 3D, from three non-coplanar directions, and synthesizing the signals into a 12-lead ECG. This platform technology is designed for portable devices that can be used wherever the patient is to deliver actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care – all outside of a medical facility, thus redefining the future of cardiac health management. HeartBeam’s 3D ECG technology received FDA clearance for arrhythmia assessment in December 2024, and the 12-Lead ECG synthesis software received FDA clearance for arrhythmia assessment in December 2025<sup>1</sup>. The Company holds over 20 issued patents related to technology enablement. For additional information, visit <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.heartbeam.com/">HeartBeam.com</a>.</p><p><strong>Forward-Looking Statements</strong></p><p>All statements in this release that are not based on historical fact are "forward-looking statements." While management has based any forward-looking statements included in this release on its current expectations, the information on which such expectations were based may change. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, as a result of various factors including those risks and uncertainties described in the Risk Factors and in Management’s Discussion and Analysis of Financial Condition and Results of Operations sections of our Forms 10-K, 10-Q and other reports filed with the SEC and available at <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="http://www.sec.gov/">www.sec.gov</a>. We urge you to consider those risks and uncertainties in evaluating our forward-looking statements. We caution readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Except as otherwise required by the federal securities laws, we disclaim any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein (or elsewhere) to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.</p><p><sup>1</sup><strong>Cleared Indications for Use</strong></p><p>The HeartBeam System with 12-Lead ECG synthesis software is FDA cleared for arrhythmia assessment. Refer to the Company’s Cleared Indications for Use at <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.heartbeam.com/indications">https://www.heartbeam.com/indications</a> for details on the intended use of its technology.</p><p>MKT-143 v0</p><p>&nbsp;</p><p>View source version on businesswire.com: <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.businesswire.com/news/home/20260507972967/en/">https://www.businesswire.com/news/home/20260507972967/en/</a></p><p><strong>Media Contact:</strong><br><a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="mailto:media@heartbeam.com">media@heartbeam.com</a></p><p><strong>Investor Relations Contact:</strong><br>Chris Tyson<br>Executive Vice President<br>MZ North America<br>Direct: 949-491-8235<br><a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="mailto:BEAT@mzgroup.us">BEAT@mzgroup.us</a><br><a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="http://www.mzgroup.us/">www.mzgroup.us</a></p><p>Source: HeartBeam, Inc.</p><p>Released May 7, 2026</p><div><div><div><div><div><div><div><div><div><div><div><div><i>Note: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.</i></div></div></div></div></div></div></div></div></div></div></div></div>

HeartBeam Expands Commercial Presence Across Four Key U.S. Markets with Addition of Premier Concierge Practice

HeartBeam partners with Atelier Health to expand its 3D ECG tech across key US concierge markets.

Others

HeartBeam (NASDAQ: BEAT) Expands Concierge Cardiology Footprint With Atelier Health Agreement

HeartBeam&#160;(NASDAQ: BEAT),&#160;a medical technology company focused on cardiac care solutions, announced a commercial agreement with Beverly Hills-based concierge medical practice Atelier Health, expanding the company’s launch footprint into Southern California and completing its initial targeted markets alongside New York metro, Dallas and South Florida as it advances commercialization of its cable-free 3D ECG technology for [&#8230;]

HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced a commercial agreement with Atelier Health, a...

HeartBeam (NASDAQ: BEAT) Tackles Heart Disease with Next-Generation ECG Solutions

Cardiovascular disease continues to be a major global health challenge, driven by aging populations, lifestyle factors and persistent gaps in early detection that continue to challenge healthcare systems. In response to these trends,&#160;HeartBeam (NASDAQ: BEAT)&#160;is developing technology aimed at improving how cardiac conditions are identified and monitored, positioning its solutions at the intersection of rising [&#8230;]

HeartBeam (NASDAQ: BEAT) to Host Q1 2026 Earnings Call and Provide Strategic Updates

HeartBeam (NASDAQ: BEAT), a medical technology company focused on cardiac care innovation, will host a conference call on May 13, 2026, at 4:30 p.m. Eastern time to discuss first-quarter results ended March 31, 2026, and provide updates on key growth initiatives, including its limited commercial launch for arrhythmia assessment, extended-wear patch development, heart attack detection [&#8230;]

HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.

BEAT
HeartBeam Inc

Feed

News

Sentiment

Fundamentals

Info

Compact View

Latest BEAT News

BEATHeartBeam Inc